204 related articles for article (PubMed ID: 31632020)
41. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
[TBL] [Abstract][Full Text] [Related]
42. Nimodipine loaded PLGA nanoparticles: formulation optimization using factorial design, characterization and in vitro evaluation.
Mehta AK; Yadav KS; Sawant KK
Curr Drug Deliv; 2007 Jul; 4(3):185-93. PubMed ID: 17627492
[TBL] [Abstract][Full Text] [Related]
43. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
44. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
45. Near IR responsive targeted integrated lipid polymer nanoconstruct for enhanced magnolol cytotoxicity in breast cancer.
Elhabak M; Osman R; Mohamed M; El-Borady OM; Awad GAS; Mortada N
Sci Rep; 2020 May; 10(1):8771. PubMed ID: 32472087
[TBL] [Abstract][Full Text] [Related]
46. The Potential of Atractylodin-Loaded PLGA Nanoparticles as Chemotherapeutic for Cholangiocarcinoma.
Muhamad N; Plengsuriyakarn T; Chittasupho C; Na-Bangchang K
Asian Pac J Cancer Prev; 2020 Apr; 21(4):935-941. PubMed ID: 32334453
[TBL] [Abstract][Full Text] [Related]
47. Antimycobacterial susceptibility evaluation of rifampicin and isoniazid benz-hydrazone in biodegradable polymeric nanoparticles against
Hakkimane SS; Shenoy VP; Gaonkar SL; Bairy I; Guru BR
Int J Nanomedicine; 2018; 13():4303-4318. PubMed ID: 30087562
[TBL] [Abstract][Full Text] [Related]
48. Effects of curcumin-loaded poly(lactic-co-glycolic acid) nanoparticles in MDA-MB231 human breast cancer cells.
Sharma A; Hawthorne S; Jha SK; Jha NK; Kumar D; Girgis S; Goswami VK; Gupta G; Singh S; Dureja H; Chellappan DK; Dua K
Nanomedicine (Lond); 2021 Aug; 16(20):1763-1773. PubMed ID: 34296625
[No Abstract] [Full Text] [Related]
49. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA.
Nair K L; Jagadeeshan S; Nair SA; Kumar GS
Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233
[TBL] [Abstract][Full Text] [Related]
50. Formulation and characterization of poly(propylacrylic acid)/poly(lactic-co-glycolic acid) blend microparticles for pH-dependent membrane disruption and cytosolic delivery.
Fernando LP; Lewis JS; Evans BC; Duvall CL; Keselowsky BG
J Biomed Mater Res A; 2018 Apr; 106(4):1022-1033. PubMed ID: 29164777
[TBL] [Abstract][Full Text] [Related]
51. Na
Araste F; Abnous K; Hashemi M; Dehshahri A; Detampel P; Alibolandi M; Ramezani M
Eur J Pharm Sci; 2020 Feb; 143():105207. PubMed ID: 31870814
[TBL] [Abstract][Full Text] [Related]
52. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.
Subramani R; Gonzalez E; Arumugam A; Nandy S; Gonzalez V; Medel J; Camacho F; Ortega A; Bonkoungou S; Narayan M; Dwivedi Ak; Lakshmanaswamy R
Sci Rep; 2016 Jan; 6():19819. PubMed ID: 26804739
[TBL] [Abstract][Full Text] [Related]
53. The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells.
Sampath M; Pichaimani A; Kumpati P; Sengottuvelan B
Int J Biol Macromol; 2020 Nov; 162():748-761. PubMed ID: 32585267
[TBL] [Abstract][Full Text] [Related]
54. GANT61 and curcumin-loaded PLGA nanoparticles for GLI1 and PI3K/Akt-mediated inhibition in breast adenocarcinoma.
Borah A; Pillai SC; Rochani AK; Palaninathan V; Nakajima Y; Maekawa T; Kumar DS
Nanotechnology; 2020 May; 31(18):185102. PubMed ID: 31952056
[TBL] [Abstract][Full Text] [Related]
55. Co-delivery nanoparticles with characteristics of intracellular precision release drugs for overcoming multidrug resistance.
Zhang D; Kong YY; Sun JH; Huo SJ; Zhou M; Gui YL; Mu X; Chen H; Yu SQ; Xu Q
Int J Nanomedicine; 2017; 12():2081-2108. PubMed ID: 28356731
[TBL] [Abstract][Full Text] [Related]
56. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.
Kashi TS; Eskandarion S; Esfandyari-Manesh M; Marashi SM; Samadi N; Fatemi SM; Atyabi F; Eshraghi S; Dinarvand R
Int J Nanomedicine; 2012; 7():221-34. PubMed ID: 22275837
[TBL] [Abstract][Full Text] [Related]
57. Development and Evaluation of Icariin-Loaded PLGA-PEG Nanoparticles for Potentiation the Proapoptotic Activity in Pancreatic Cancer Cells.
Alhakamy NA
AAPS PharmSciTech; 2021 Oct; 22(8):252. PubMed ID: 34668089
[TBL] [Abstract][Full Text] [Related]
58. Effects of Nanoparticle Properties on Kartogenin Delivery and Interactions with Mesenchymal Stem Cells.
Almeida B; Wang Y; Shukla A
Ann Biomed Eng; 2020 Jul; 48(7):2090-2102. PubMed ID: 31807926
[TBL] [Abstract][Full Text] [Related]
59. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
[TBL] [Abstract][Full Text] [Related]
60. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
Chen SH; Liu TI; Chuang CL; Chen HH; Chiang WH; Chiu HC
J Mater Chem B; 2020 May; 8(17):3789-3800. PubMed ID: 32150202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]